The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals

Danielle Dunlea, Laura Fee, Thomas McEnery, Noel G. McElvaney, Emer Reeves
  • Journal of Inflammation Research, March 2018, Dove Medical Press
  • DOI: 10.2147/jir.s156405
The author haven't yet claimed this publicationThe author haven't yet claimed this publication
open access logoRead Publication

http://dx.doi.org/10.2147/jir.s156405

In partnership with: